백신 전달 장치 시장 규모, 점유율, 동향 분석 보고서 : 장치별, 투여 경로별, 지역별, 부문 예측(2025-2030년)

Vaccine Delivery Devices Market Size, Share & Trends Analysis Report By Device, By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

백신 전달 장치 시장의 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 백신 전달 장치 시장 규모는 2030년까지 115억 달러에 달할 것으로 예상됩니다.

이 시장은 2024년부터 2030년까지 7.6%의 연평균 성장률을 보일 것으로 예상됩니다. 이 시장은 주로 예방 접종 프로그램 증가, 정부 및 비정부 기관의 재정 지원, 예방 접종 및 캠페인 증가, 전 세계적으로 증가하는 전염병 유병률에 의해 주도되고 있습니다. 백신 분야의 연구와 신제품 개발이 증가하는 것도 시장 성장에 기여하고 있습니다.

주사바늘 사용으로 인한 통증과 부상을 피하려는 인식과 수요가 증가함에 따라 이러한 제품을 투여할 때 바늘이 없는 방식을 채택하는 것이 탄력을 받고 있습니다. 미국 질병통제예방센터의 데이터에 따르면 매년 미국 병원에서 주사바늘 부상을 포함한 날카로운 부상이 약 385,000건 발생한다고 합니다. 백신 투여 기술의 발전과 백신의 채택 증가는 시장 성장을 촉진하고 있습니다. 새로운 전달 기술에 대한 다양한 주요 업체, 국가 기관 및 조직의 관심이 높아짐에 따라 시장 성장에 더욱 기여할 것으로 예상됩니다.

특히 바이러스 확산에 대처하기 위한 백신에 대한 수요 증가로 인해 코로나19 전염병이 시장 성장을 크게 촉진했습니다. 백신 기기 제조업체와 정부의 연구 개발에 대한 투자가 증가하면서 시장이 빠른 속도로 크게 확대되었습니다. 유니세프, Gavi, WHO와 같은 다양한 규제 당국의 지원도 시장 성장을 촉진할 것으로 예상됩니다.

다양한 정부와 국제기구가 백신 프로그램 개발에 점점 더 많은 투자를 하고 있습니다. 예를 들어, 영국 정부는 지카 바이러스와 그 전파를 조사하기 위해 의학 연구 위원회를 통해 세계의 도전 연구 기금에서 최대 100만 파운드의 자금을 지원한다고 발표했습니다. 세계백신면역연합, 빌&멜린다 게이츠 재단, 패스, 세계보건기구(WHO) 등의 단체도 백신 분야에 적극적으로 참여하고 있습니다. 또한 많은 정부가 우선순위에 따라 여러 예방 접종 프로그램을 진행하고 있습니다.

백신 전달 장치 시장 보고서 하이라이트

• 장치별로 백신 프로그램 증가, 예방 접종 범위 확대, 기술 발전으로 인해 주사기 부문이 2024년 가장 큰 매출 점유율을 차지했습니다.
• 투여 경로별로 피내 백신 접종은 장점으로 인해 대부분의 백신이 이 경로를 통해 투여되기 때문에 2024년 시장을 지배했습니다.
• 북미는 인식 수준 증가, 높은 기술 채택, 전염병 유병률 증가로 인해 2024년 세계의 시장을 지배했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 백신 전달 장치 시장의 변수, 동향, 범위

• 시장 계통의 전망
  • 상위 시장 전망
  • 관련 및 부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 백신 전달 장치 시장 분석 도구
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 백신 전달 장치 시장 : 장치별, 추정 및 동향 분석

• 부문 대시보드
• 백신 전달 장치 시장 : 장치 변동 분석
• 백신 전달 장치 시장 : 장치별 전망
• 시장 규모와 예측과 동향 분석(2018-2030년)
• 주사기
• 제트 인젝터
• 기타

제5장 백신 전달 장치 시장 : 투여 경로별, 추정 및 동향 분석

• 부문 대시보드
• 백신 전달 장치 시장 : 투여 경로 변동 분석
• 백신 전달 장치 시장 : 투여 경로별 전망
• 시장 규모와 예측과 동향 분석(2018-2030년)
• 피내 백신 접종
• 근육내 백신 접종
• 피하 백신 접종
• 기타

제6장 백신 전달 장치 시장 : 지역별, 추정 및 동향 분석

• 지역 대시보드
• 지역별 백신 전달 장치 시장 변동 분석
• 백신 전달 장치 시장 : 지역 추정 및 동향 분석(2018-2030년)
• 시장 규모와 예측과 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 환급 시나리오
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 시장 진출기업의 분류
• 주요 기업 프로파일
  • BD
  • Bioject Medical Technologies, Inc.(Inovio Pharmaceutical Inc.)
  • PharmaJet
  • Vaxxas
  • Gerresheimer AG
  • SCHOTT AG
  • Corium International, Inc.
  • 3M

HBR

영문 목차

영문목차

Vaccine Delivery Devices Market Growth & Trends:

The global vaccine delivery devices market size is anticipated to reach USD 11.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 7.6% from 2024 to 2030. The market is primarily driven by growing immunization programs, financial support from government and non-government organizations, increasing vaccination initiatives and campaigns, and the rising prevalence of infectious diseases globally. Growing research in the field of vaccines and the development of new products are also contributing to the growth of the market.

The adoption of a needle-free approach for administering these products is gaining momentum due to the growing awareness and demand to avoid pain and injuries associated with the use of a needle stick. Data by the Centers for Disease Control and Prevention states that an estimated 385,000 sharp injuries including needle stick injuries occur every year in hospitals in the U.S. Advancing technologies in administering vaccines and their increasing adoption is propelling the market growth. The rising interest of various key players, national institutions, and organizations in novel delivery technologies is expected to further contribute to market growth.

The Covid-19 epidemic significantly boosted the market growth, especially due to the increasing demand for vaccination to tackle the spread of the virus. Increasing investment in Research & Development by vaccination device manufacturers as well as the governments has expanded the market significantly at an accelerated pace. Initiatives are undertaken by various regulatory authorities like UNICEF, Gavi, and WHO are also expected to boost the market growth.

Various governments and international organizations are increasingly investing in the development of vaccination programs. For instance, the U.K. government also announced funding of up to £1 million from its Global Challenges Research Fund through Medical Research Council to investigate the Zika virus and its transmission. Organizations such as GAVI Alliance, Bill & Melinda Gates Foundation, Path, and the WHO are actively involved in the field of vaccines. Many governments are also undertaking several immunization programs on priority.

Vaccine Delivery Devices Market Report Highlights:

• By device, the syringes segment held the largest revenue share in 2024 due to the increasing vaccination programs, spreading immunization coverage, and technological advancements
• By route of administration, intradermal vaccination dominated the market in 2024 as the majority of vaccines are given through this route owing to its advantages
• North America dominated the global market in 2024 owing to the increasing awareness levels, high adoption of technology, and the rising prevalence of infectious diseases

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Device
  • 1.2.2. Route of Administration
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Device outlook
  • 2.2.2. Route of Administration outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Vaccine Delivery Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Vaccine Delivery Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Vaccine Delivery Devices Market: Device Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Vaccine Delivery Devices Market: Device Movement Analysis
• 4.3. Vaccine Delivery Devices Market by Device Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Syringes
  • 4.5.1. Syringes Vaccine Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Jet Injectors
  • 4.6.1. Jet Injectors Vaccine Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Vaccine Delivery Devices Market: Route of Administration Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Vaccine Delivery Devices Market: Route of Administration Movement Analysis
• 5.3. Vaccine Delivery Devices Market by Route of Administration Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Intradermal Vaccination
  • 5.5.1. Intradermal Vaccination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Intramuscular Vaccination
  • 5.6.1. Intramuscular Vaccination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Subcutaneous Vaccination
  • 5.7.1. Subcutaneous Vaccination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Vaccine Delivery Devices Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Vaccine Delivery Devices Market Movement Analysis
• 6.3. Vaccine Delivery Devices Market: Regional Estimates & Trend Analysis 2018 to 2030 for the following
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1 Key Country Dynamics
    • 6.5.2.2 Competitive Scenario
    • 6.5.2.3 Regulatory Framework
    • 6.5.2.4 Reimbursement scenario
    • 6.5.2.5 U.S. Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1 Key Country Dynamics
    • 6.5.3.2 Competitive Scenario
    • 6.5.3.3 Regulatory Framework
    • 6.5.3.4 Reimbursement scenario
    • 6.5.3.5 Canada Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1 Key Country Dynamics
    • 6.5.4.2 Competitive Scenario
    • 6.5.4.3 Regulatory Framework
    • 6.5.4.4 Reimbursement scenario
    • 6.5.4.5 Mexico Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1 Key Country Dynamics
    • 6.6.2.2 Competitive Scenario
    • 6.6.2.3 Regulatory Framework
  • 6.6.24 Reimbursement scenario
    • 6.6.2.5 UK Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1 Key Country Dynamics
    • 6.6.3.2 Competitive Scenario
    • 6.6.3.3 Regulatory Framework
    • 6.6.3.4 Reimbursement scenario
    • 6.6.3.5 Germany Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. France
    • 6.6.4.1 Key Country Dynamics
    • 6.6.4.2 Competitive Scenario
    • 6.6.4.3 Regulatory Framework
    • 6.6.4.4 Reimbursement scenario
    • 6.6.4.5 France Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1 Key Country Dynamics
    • 6.6.5.2 Competitive Scenario
    • 6.6.5.3 Regulatory Framework
    • 6.6.5.4 Reimbursement scenario
    • 6.6.5.5 Italy Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1 Key Country Dynamics
    • 6.6.6.2 Competitive Scenario
    • 6.6.6.3 Regulatory Framework
    • 6.6.6.4 Reimbursement scenario
    • 6.6.6.5 Spain Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Denmark
    • 6.6.7.1 Key Country Dynamics
    • 6.6.7.2 Competitive Scenario
    • 6.6.7.3 Regulatory Framework
    • 6.6.7.4 Reimbursement scenario
    • 6.6.7.5 Denmark Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1 Key Country Dynamics
    • 6.6.8.2 Competitive Scenario
    • 6.6.8.3 Regulatory Framework
    • 6.6.8.4 Reimbursement scenario
    • 6.6.8.5 Sweden Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.9. Norway
    • 6.6.9.1 Key Country Dynamics
    • 6.6.9.2 Competitive Scenario
    • 6.6.9.3 Regulatory Framework
    • 6.6.9.4 Reimbursement scenario
    • 6.6.9.5 Norway Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Asia Pacific Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Japan
    • 6.7.2.1 Key Country Dynamics
    • 6.7.2.2 Competitive Scenario
    • 6.7.2.3 Regulatory Framework
    • 6.7.2.4 Reimbursement scenario
    • 6.7.2.5 Japan Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. China
    • 6.7.3.1 Key Country Dynamics
    • 6.7.3.2 Competitive Scenario
    • 6.7.3.3 Regulatory Framework
    • 6.7.3.4 Reimbursement scenario
    • 6.7.3.5 China Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.4. India
    • 6.7.4.1 Key Country Dynamics
    • 6.7.4.2 Competitive Scenario
    • 6.7.4.3 Regulatory Framework
    • 6.7.4.4 Reimbursement scenario
    • 6.7.4.5 India Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1 Key Country Dynamics
    • 6.7.5.2 Competitive Scenario
    • 6.7.5.3 Regulatory Framework
    • 6.7.5.4 Reimbursement scenario
    • 6.7.5.5 South Korea Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.6. Australia
    • 6.7.6.1 Key Country Dynamics
    • 6.7.6.2 Competitive Scenario
    • 6.7.6.3 Regulatory Framework
    • 6.7.6.4 Reimbursement scenario
    • 6.7.6.5 Australia Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1 Key Country Dynamics
    • 6.7.7.2 Competitive Scenario
    • 6.7.7.3 Regulatory Framework
    • 6.7.7.4 Reimbursement scenario
    • 6.7.7.5 Thailand Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Latin America Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. Brazil
    • 6.8.2.1 Key Country Dynamics
    • 6.8.2.2 Competitive Scenario
    • 6.8.2.3 Regulatory Framework
    • 6.8.2.4 Reimbursement scenario
    • 6.8.2.5 Brazil Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1 Key Country Dynamics
    • 6.8.3.2 Competitive Scenario
    • 6.8.3.3 Regulatory Framework
    • 6.8.3.4 Reimbursement scenario
    • 6.8.3.5 Argentina Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Middle East & Africa
  • 6.9.1. Middle East & Africa Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.2. South Africa
    • 6.9.2.1 Key Country Dynamics
    • 6.9.2.2 Competitive Scenario
    • 6.9.2.3 Regulatory Framework
    • 6.9.2.4 Reimbursement scenario
    • 6.9.2.5 South Africa Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1 Key Country Dynamics
    • 6.9.30.2 Competitive Scenario
    • 6.9.3.3 Regulatory Framework
    • 6.9.3.4 Reimbursement scenario
    • 6.9.3.5 Saudi Arabia Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1 Key Country Dynamics
    • 6.9.4.2 Competitive Scenario
    • 6.9.4.3 Regulatory Framework
    • 6.9.4.4 Reimbursement scenario
    • 6.9.4.5 UAE Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1 Key Country Dynamics
    • 6.9.5.2 Competitive Scenario
    • 6.9.52.3 Regulatory Framework
    • 6.9.5.4 Reimbursement scenario
    • 6.9.5.5 Kuwait Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. BD
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. PharmaJet
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. . Vaxxas
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Gerresheimer AG
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. SCHOTT AG
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Corium International, Inc.
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. 3M
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives

관련자료